Click for best price
Human Coagulation Factor VIII Market Size, Share 2023
| Market size in 2022 |
US$ 10530 million
|
Forecast Market size by 2029 |
US$ 15860 million
|
| Growth Rate |
CAGR of 6.0% |
Number of Pages |
75 Pages |
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P?), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII. This report contains market size and forecasts of Human Coagulation Factor VIII in global, including the following market information:
Global Human Coagulation Factor VIII Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Coagulation Factor VIII Market Sales, 2018-2023, 2024-2029, (K Bottles)
Global top five Human Coagulation Factor VIII companies in 2022 (%)
The global Human Coagulation Factor VIII market was valued at US$ 10530 million in 2022 and is projected to reach US$ 15860 million by 2029, at a CAGR of 6.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.
We surveyed the Human Coagulation Factor VIII manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Coagulation Factor VIII Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Bottles)
Global Human Coagulation Factor VIII Market Segment Percentages, by Type, 2022 (%)
Recombinant Factor VIII
Plasma-derived Factor VIII
Global Human Coagulation Factor VIII Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Bottles)
Global Human Coagulation Factor VIII Market Segment Percentages, by Application, 2022 (%)
Hemophilia A
Spontanous / Trauma
Surgical
Other
Global Human Coagulation Factor VIII Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Bottles)
Global Human Coagulation Factor VIII Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Coagulation Factor VIII revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Coagulation Factor VIII revenues share in global market, 2022 (%)
Key companies Human Coagulation Factor VIII sales in global market, 2018-2023 (Estimated), (K Bottles)
Key companies Human Coagulation Factor VIII sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Coagulation Factor VIII, market overview.
Chapter 2: Global Human Coagulation Factor VIII market size in revenue and volume.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Coagulation Factor VIII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Coagulation Factor VIII capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Human Coagulation Factor VIII Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 10530 million
|
| Forecast Market size by 2029 |
US$ 15860 million
|
| Growth Rate |
CAGR of 6.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
75 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Coagulation Factor VIII Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Coagulation Factor VIII Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Coagulation Factor VIII Overall Market Size
2.1 Global Human Coagulation Factor VIII Market Size: 2022 VS 2029
2.2 Global Human Coagulation Factor VIII Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Coagulation Factor VIII Sales: 2018-2029
3 Company Landscape
3.1 Top Human Coagulation Factor VIII Players in Global Market
3.2 Top Global Human Coagulation Factor VIII Companies Ranked by Revenue
3.3 Global Human Coagulation Factor VIII Revenue by Companies
3.4 Global Human Coagulation Factor VIII Sales by Companies
3.5 Global Human Coagulation Factor VIII Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Coagulation Factor VIII Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Coagulation Factor VIII Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Coagulation Factor VIII Players in Global Market
3.8.1 List of Global Tier 1 Human Coagulation Factor VIII Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Coagulation Factor VIII Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Coagulation Factor VIII Market Size Markets, 2022 & 2029
4.1.2 Recombinant Factor VIII
4.1.3 Plasma-derived Factor VIII
4.2 By Type - Global Human Coagulation Factor VIII Revenue & Forecasts
4.2.1 By Type - Global Human Coagulation Factor VIII Revenue, 2018-2023
4.2.2 By Type - Global Human Coagulation Factor VIII Revenue, 2024-2029
4.2.3 By Type - Global Human Coagulation Factor VIII Revenue Market Share, 2018-2029
4.3 By Type - Global Human Coagulation Factor VIII Sales & Forecasts
4.3.1 By Type - Global Human Coagulation Factor VIII Sales, 2018-2023
4.3.2 By Type - Global Human Coagulation Factor VIII Sales, 2024-2029
4.3.3 By Type - Global Human Coagulation Factor VIII Sales Market Share, 2018-2029
4.4 By Type - Global Human Coagulation Factor VIII Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Coagulation Factor VIII Market Size, 2022 & 2029
5.1.2 Hemophilia A
5.1.3 Spontanous / Trauma
5.1.4 Surgical
5.1.5 Other
5.2 By Application - Global Human Coagulation Factor VIII Revenue & Forecasts
5.2.1 By Application - Global Human Coagulation Factor VIII Revenue, 2018-2023
5.2.2 By Application - Global Human Coagulation Factor VIII Revenue, 2024-2029
5.2.3 By Application - Global Human Coagulation Factor VIII Revenue Market Share, 2018-2029
5.3 By Application - Global Human Coagulation Factor VIII Sales & Forecasts
5.3.1 By Application - Global Human Coagulation Factor VIII Sales, 2018-2023
5.3.2 By Application - Global Human Coagulation Factor VIII Sales, 2024-2029
5.3.3 By Application - Global Human Coagulation Factor VIII Sales Market Share, 2018-2029
5.4 By Application - Global Human Coagulation Factor VIII Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Human Coagulation Factor VIII Market Size, 2022 & 2029
6.2 By Region - Global Human Coagulation Factor VIII Revenue & Forecasts
6.2.1 By Region - Global Human Coagulation Factor VIII Revenue, 2018-2023
6.2.2 By Region - Global Human Coagulation Factor VIII Revenue, 2024-2029
6.2.3 By Region - Global Human Coagulation Factor VIII Revenue Market Share, 2018-2029
6.3 By Region - Global Human Coagulation Factor VIII Sales & Forecasts
6.3.1 By Region - Global Human Coagulation Factor VIII Sales, 2018-2023
6.3.2 By Region - Global Human Coagulation Factor VIII Sales, 2024-2029
6.3.3 By Region - Global Human Coagulation Factor VIII Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Human Coagulation Factor VIII Revenue, 2018-2029
6.4.2 By Country - North America Human Coagulation Factor VIII Sales, 2018-2029
6.4.3 US Human Coagulation Factor VIII Market Size, 2018-2029
6.4.4 Canada Human Coagulation Factor VIII Market Size, 2018-2029
6.4.5 Mexico Human Coagulation Factor VIII Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Human Coagulation Factor VIII Revenue, 2018-2029
6.5.2 By Country - Europe Human Coagulation Factor VIII Sales, 2018-2029
6.5.3 Germany Human Coagulation Factor VIII Market Size, 2018-2029
6.5.4 France Human Coagulation Factor VIII Market Size, 2018-2029
6.5.5 U.K. Human Coagulation Factor VIII Market Size, 2018-2029
6.5.6 Italy Human Coagulation Factor VIII Market Size, 2018-2029
6.5.7 Russia Human Coagulation Factor VIII Market Size, 2018-2029
6.5.8 Nordic Countries Human Coagulation Factor VIII Market Size, 2018-2029
6.5.9 Benelux Human Coagulation Factor VIII Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Human Coagulation Factor VIII Revenue, 2018-2029
6.6.2 By Region - Asia Human Coagulation Factor VIII Sales, 2018-2029
6.6.3 China Human Coagulation Factor VIII Market Size, 2018-2029
6.6.4 Japan Human Coagulation Factor VIII Market Size, 2018-2029
6.6.5 South Korea Human Coagulation Factor VIII Market Size, 2018-2029
6.6.6 Southeast Asia Human Coagulation Factor VIII Market Size, 2018-2029
6.6.7 India Human Coagulation Factor VIII Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Human Coagulation Factor VIII Revenue, 2018-2029
6.7.2 By Country - South America Human Coagulation Factor VIII Sales, 2018-2029
6.7.3 Brazil Human Coagulation Factor VIII Market Size, 2018-2029
6.7.4 Argentina Human Coagulation Factor VIII Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Coagulation Factor VIII Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Human Coagulation Factor VIII Sales, 2018-2029
6.8.3 Turkey Human Coagulation Factor VIII Market Size, 2018-2029
6.8.4 Israel Human Coagulation Factor VIII Market Size, 2018-2029
6.8.5 Saudi Arabia Human Coagulation Factor VIII Market Size, 2018-2029
6.8.6 UAE Human Coagulation Factor VIII Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Shire (Baxter)
7.1.1 Shire (Baxter) Company Summary
7.1.2 Shire (Baxter) Business Overview
7.1.3 Shire (Baxter) Human Coagulation Factor VIII Major Product Offerings
7.1.4 Shire (Baxter) Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.1.5 Shire (Baxter) Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Human Coagulation Factor VIII Major Product Offerings
7.2.4 Bayer Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 CSL
7.3.1 CSL Company Summary
7.3.2 CSL Business Overview
7.3.3 CSL Human Coagulation Factor VIII Major Product Offerings
7.3.4 CSL Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.3.5 CSL Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Human Coagulation Factor VIII Major Product Offerings
7.4.4 Pfizer Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Grifols
7.5.1 Grifols Company Summary
7.5.2 Grifols Business Overview
7.5.3 Grifols Human Coagulation Factor VIII Major Product Offerings
7.5.4 Grifols Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.5.5 Grifols Key News & Latest Developments
7.6 Biogen
7.6.1 Biogen Company Summary
7.6.2 Biogen Business Overview
7.6.3 Biogen Human Coagulation Factor VIII Major Product Offerings
7.6.4 Biogen Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.6.5 Biogen Key News & Latest Developments
7.7 Octapharma
7.7.1 Octapharma Company Summary
7.7.2 Octapharma Business Overview
7.7.3 Octapharma Human Coagulation Factor VIII Major Product Offerings
7.7.4 Octapharma Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.7.5 Octapharma Key News & Latest Developments
7.8 NovoNordisk
7.8.1 NovoNordisk Company Summary
7.8.2 NovoNordisk Business Overview
7.8.3 NovoNordisk Human Coagulation Factor VIII Major Product Offerings
7.8.4 NovoNordisk Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.8.5 NovoNordisk Key News & Latest Developments
7.9 Greencross
7.9.1 Greencross Company Summary
7.9.2 Greencross Business Overview
7.9.3 Greencross Human Coagulation Factor VIII Major Product Offerings
7.9.4 Greencross Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.9.5 Greencross Key News & Latest Developments
7.10 Kedrion
7.10.1 Kedrion Company Summary
7.10.2 Kedrion Business Overview
7.10.3 Kedrion Human Coagulation Factor VIII Major Product Offerings
7.10.4 Kedrion Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.10.5 Kedrion Key News & Latest Developments
7.11 BPL
7.11.1 BPL Company Summary
7.11.2 BPL Human Coagulation Factor VIII Business Overview
7.11.3 BPL Human Coagulation Factor VIII Major Product Offerings
7.11.4 BPL Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.11.5 BPL Key News & Latest Developments
7.12 Hualan Bio
7.12.1 Hualan Bio Company Summary
7.12.2 Hualan Bio Human Coagulation Factor VIII Business Overview
7.12.3 Hualan Bio Human Coagulation Factor VIII Major Product Offerings
7.12.4 Hualan Bio Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.12.5 Hualan Bio Key News & Latest Developments
7.13 RAAS
7.13.1 RAAS Company Summary
7.13.2 RAAS Human Coagulation Factor VIII Business Overview
7.13.3 RAAS Human Coagulation Factor VIII Major Product Offerings
7.13.4 RAAS Human Coagulation Factor VIII Sales and Revenue in Global (2018-2023)
7.13.5 RAAS Key News & Latest Developments
8 Global Human Coagulation Factor VIII Production Capacity, Analysis
8.1 Global Human Coagulation Factor VIII Production Capacity, 2018-2029
8.2 Human Coagulation Factor VIII Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Coagulation Factor VIII Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Coagulation Factor VIII Supply Chain Analysis
10.1 Human Coagulation Factor VIII Industry Value Chain
10.2 Human Coagulation Factor VIII Upstream Market
10.3 Human Coagulation Factor VIII Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Coagulation Factor VIII Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Human Coagulation Factor VIII in Global Market
Table 2. Top Human Coagulation Factor VIII Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Coagulation Factor VIII Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Coagulation Factor VIII Revenue Share by Companies, 2018-2023
Table 5. Global Human Coagulation Factor VIII Sales by Companies, (K Bottles), 2018-2023
Table 6. Global Human Coagulation Factor VIII Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Coagulation Factor VIII Price (2018-2023) & (USD/Bottle)
Table 8. Global Manufacturers Human Coagulation Factor VIII Product Type
Table 9. List of Global Tier 1 Human Coagulation Factor VIII Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Coagulation Factor VIII Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Coagulation Factor VIII Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Coagulation Factor VIII Sales (K Bottles), 2018-2023
Table 15. By Type - Global Human Coagulation Factor VIII Sales (K Bottles), 2024-2029
Table 16. By Application ? Global Human Coagulation Factor VIII Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Coagulation Factor VIII Sales (K Bottles), 2018-2023
Table 20. By Application - Global Human Coagulation Factor VIII Sales (K Bottles), 2024-2029
Table 21. By Region ? Global Human Coagulation Factor VIII Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Coagulation Factor VIII Sales (K Bottles), 2018-2023
Table 25. By Region - Global Human Coagulation Factor VIII Sales (K Bottles), 2024-2029
Table 26. By Country - North America Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Coagulation Factor VIII Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Coagulation Factor VIII Sales, (K Bottles), 2018-2023
Table 29. By Country - North America Human Coagulation Factor VIII Sales, (K Bottles), 2024-2029
Table 30. By Country - Europe Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Coagulation Factor VIII Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Coagulation Factor VIII Sales, (K Bottles), 2018-2023
Table 33. By Country - Europe Human Coagulation Factor VIII Sales, (K Bottles), 2024-2029
Table 34. By Region - Asia Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Coagulation Factor VIII Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Coagulation Factor VIII Sales, (K Bottles), 2018-2023
Table 37. By Region - Asia Human Coagulation Factor VIII Sales, (K Bottles), 2024-2029
Table 38. By Country - South America Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Coagulation Factor VIII Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Coagulation Factor VIII Sales, (K Bottles), 2018-2023
Table 41. By Country - South America Human Coagulation Factor VIII Sales, (K Bottles), 2024-2029
Table 42. By Country - Middle East & Africa Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Coagulation Factor VIII Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Coagulation Factor VIII Sales, (K Bottles), 2018-2023
Table 45. By Country - Middle East & Africa Human Coagulation Factor VIII Sales, (K Bottles), 2024-2029
Table 46. Shire (Baxter) Company Summary
Table 47. Shire (Baxter) Human Coagulation Factor VIII Product Offerings
Table 48. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 49. Shire (Baxter) Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Human Coagulation Factor VIII Product Offerings
Table 52. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. CSL Company Summary
Table 55. CSL Human Coagulation Factor VIII Product Offerings
Table 56. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 57. CSL Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Human Coagulation Factor VIII Product Offerings
Table 60. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Grifols Company Summary
Table 63. Grifols Human Coagulation Factor VIII Product Offerings
Table 64. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 65. Grifols Key News & Latest Developments
Table 66. Biogen Company Summary
Table 67. Biogen Human Coagulation Factor VIII Product Offerings
Table 68. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 69. Biogen Key News & Latest Developments
Table 70. Octapharma Company Summary
Table 71. Octapharma Human Coagulation Factor VIII Product Offerings
Table 72. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 73. Octapharma Key News & Latest Developments
Table 74. NovoNordisk Company Summary
Table 75. NovoNordisk Human Coagulation Factor VIII Product Offerings
Table 76. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 77. NovoNordisk Key News & Latest Developments
Table 78. Greencross Company Summary
Table 79. Greencross Human Coagulation Factor VIII Product Offerings
Table 80. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 81. Greencross Key News & Latest Developments
Table 82. Kedrion Company Summary
Table 83. Kedrion Human Coagulation Factor VIII Product Offerings
Table 84. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 85. Kedrion Key News & Latest Developments
Table 86. BPL Company Summary
Table 87. BPL Human Coagulation Factor VIII Product Offerings
Table 88. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 89. BPL Key News & Latest Developments
Table 90. Hualan Bio Company Summary
Table 91. Hualan Bio Human Coagulation Factor VIII Product Offerings
Table 92. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 93. Hualan Bio Key News & Latest Developments
Table 94. RAAS Company Summary
Table 95. RAAS Human Coagulation Factor VIII Product Offerings
Table 96. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$, Mn) and Average Price (USD/Bottle) (2018-2023)
Table 97. RAAS Key News & Latest Developments
Table 98. Human Coagulation Factor VIII Production Capacity (K Bottles) of Key Manufacturers in Global Market, 2021-2023 (K Bottles)
Table 99. Global Human Coagulation Factor VIII Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Human Coagulation Factor VIII Production by Region, 2018-2023 (K Bottles)
Table 101. Global Human Coagulation Factor VIII Production by Region, 2024-2029 (K Bottles)
Table 102. Human Coagulation Factor VIII Market Opportunities & Trends in Global Market
Table 103. Human Coagulation Factor VIII Market Drivers in Global Market
Table 104. Human Coagulation Factor VIII Market Restraints in Global Market
Table 105. Human Coagulation Factor VIII Raw Materials
Table 106. Human Coagulation Factor VIII Raw Materials Suppliers in Global Market
Table 107. Typical Human Coagulation Factor VIII Downstream
Table 108. Human Coagulation Factor VIII Downstream Clients in Global Market
Table 109. Human Coagulation Factor VIII Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Coagulation Factor VIII Segment by Type in 2022
Figure 2. Human Coagulation Factor VIII Segment by Application in 2022
Figure 3. Global Human Coagulation Factor VIII Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Coagulation Factor VIII Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Coagulation Factor VIII Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Coagulation Factor VIII Sales in Global Market: 2018-2029 (K Bottles)
Figure 8. The Top 3 and 5 Players Market Share by Human Coagulation Factor VIII Revenue in 2022
Figure 9. By Type - Global Human Coagulation Factor VIII Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Coagulation Factor VIII Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Coagulation Factor VIII Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Coagulation Factor VIII Price (USD/Bottle), 2018-2029
Figure 13. By Application - Global Human Coagulation Factor VIII Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Coagulation Factor VIII Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Coagulation Factor VIII Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Coagulation Factor VIII Price (USD/Bottle), 2018-2029
Figure 17. By Region - Global Human Coagulation Factor VIII Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Coagulation Factor VIII Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Coagulation Factor VIII Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Coagulation Factor VIII Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Coagulation Factor VIII Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Coagulation Factor VIII Sales Market Share, 2018-2029
Figure 23. US Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Coagulation Factor VIII Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Coagulation Factor VIII Sales Market Share, 2018-2029
Figure 28. Germany Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Coagulation Factor VIII Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Coagulation Factor VIII Sales Market Share, 2018-2029
Figure 37. China Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Coagulation Factor VIII Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Coagulation Factor VIII Sales Market Share, 2018-2029
Figure 44. Brazil Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Coagulation Factor VIII Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Coagulation Factor VIII Sales Market Share, 2018-2029
Figure 48. Turkey Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Coagulation Factor VIII Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Coagulation Factor VIII Production Capacity (K Bottles), 2018-2029
Figure 53. The Percentage of Production Human Coagulation Factor VIII by Region, 2022 VS 2029
Figure 54. Human Coagulation Factor VIII Industry Value Chain
Figure 55. Marketing Channels
